Home » Yamanouchi Discovers Target Molecule for Antiobesity, Antidiabetic Drug
Yamanouchi Discovers Target Molecule for Antiobesity, Antidiabetic Drug
Yamanouchi Pharmaceutical announced that it has discovered a promising target molecule for the development of anti-obesity and antidiabetic drug, in collaboration with Keio University. Through mice experiments, the joint research group has confirmed that an Angiopoietin-related growth factor (AGF) has properties to improve obesity and diabetic symptoms. AGF is a protein secreted by liver.
Medical News Today (http://www.medicalnewstoday.com/medicalnews.php?newsid=21880&nfid=rssfeeds)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May